GDF-8

GDF-8

GDF-8 詳細

Molecule Name
Growth/differentiation factor 8
分子の別称
GDF-8, Myostatin, GDF8, MSTN, Growth,differentiation factor 8
Drug Development Progress
治験薬の数8
市販薬剤の数0
研究&開発段階NDA/BLA
ターゲットの別称
MSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
バックグランド
Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

GDF-8 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb Company
Muscular Atrophy, Spinal; Muscular Dystrophy, Duchenne; Neuromuscular Diseases; Obesity; Overweight
詳細
EmugrobartGYM-329; RG-6237; RG-70240; RO-7204239Phase 3 ClinicalChugai Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2; Muscular Atrophy, Spinal; Muscular Dystrophy, Facioscapulohumeral; Obesity; Overweight
詳細
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Myositis, Inclusion Body; Obesity; Sarcopenia
詳細
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S Hospital
Becker muscular dystrophy; Muscular Dystrophy, Duchenne; Myositis, Inclusion Body
詳細
EL-22EL-22Phase 1 Clinical
Obesity
詳細
IBIO-600IBIO-600Phase 1 ClinicalAstralBio Inc
Obesity; Overweight
詳細
RinvaterceptRKER-065; KER-065Phase 1 ClinicalKeros Therapeutics Inc
Neuromuscular Diseases; Obesity
詳細
SRK-439SRK-439Phase 1 ClinicalScholar Rock Inc
Heart Diseases; Obesity
詳細